Human medicines European public assessment report (EPAR): Bildyos, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Bilprevda, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Elevidys, delandistrogene moxeparvovec, Status: Opinion
Human medicines European public assessment report (EPAR): Eyluxvi, aflibercept, Status: Opinion
Human medicines European public assessment report (EPAR): Macitentan Accord, macitentan, Status: Opinion
Human medicines European public assessment report (EPAR): Macitentan AccordPharma, macitentan, Status: Opinion
Human medicines European public assessment report (EPAR): Usrenty, ustekinumab, Status: Opinion
Summary of opinion: Alhemo, 24/07/2025 Positive
Summary of opinion: mResvia, 24/07/2025 Positive
Summary of opinion: Taltz, 24/07/2025 Positive